Browse Trials

➤

Find Breast Cancer Clinical Trials That Are Right For You

The clinical trials listed below are open in the U.S. for people with DCIS (stage 0), stage 1, stage 2, stage 3, or stage 4 (metastatic)
breast cancer. Clinical trials are available for people who are newly diagnosed with breast cancer, currently in treatment, experiencing
breast cancer recurrence, living with metastatic disease, as well as breast cancer survivors who have completed treatment.

Use the search box and filters to find a trial that’s right for you.

Currently viewing trials
(Last updated: July 11, 2025)

and or

Reset

Zip Code:

Narrow my choices:

Radius (miles): All U.S.

All U.S.

Early stage

Advanced

Treatment

Non-treatment

Phase I II III

Display Only New Trials

AKT

ALK

BARD1

BRCA1/2 (tumor)

BRIP1

CD205

CD70

CHEK2 or CHEK1

dMMR/MSI-H

ESR1

FGFR

HER2/ERBB2

HLA

MET or C-Met

NTRK

PALB2

PIK3CA or PI3K

PTEN

RAD51

RAF (including BRAF)

RAS (KRAS or NRAS)

ROS1

TP53

Click here to view online studies and trials that do not require site visits

NEAREST SITE: 3 miles
Zuckerberg San Francisco General
San Francisco,CA

VISITS: Up to 2 visits every month for 6 months

PHASE: NA

NCT ID: NCT06633926

Nutrition, Yoga, and Healing Touch Program to Improve Quality of Life for Stage I-III Breast Cancer

Integrative Approaches for Cancer Survivorship: A Multi-Site Feasibility and Acceptability Study (Aim 2) (IACS3) Scientific Title

Purpose

To study if the Ayurveda nutrition, yoga, and healing touch program improves quality of life and cancer-associated symptoms.

Who is this for?

People with stage I, stage II, or stage III breast cancer who completed treatment less than 3 years ago. You must have received chemotherapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Ayurveda (nutrition, yoga, healing touch) program, in person, 2 times every month for 6 months</li> <li class="seamTextUnorderedListItem">Virtual meeting, monthly for 6 months (optional)</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Health education program, virtual, 2 times every month for 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Ayurveda program includes nutrition education, lifestyle practices, yoga, and therapeutic touch to help the body and mind feel balanced.</li> <li class="seamTextUnorderedListItem">The health education program includes interactive videos based on the latest science in cancer survivorship.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06633926' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 3 miles
Kaiser Permanente-San Francisco
San Francisco,CA

VISITS: 3 visits in 1 year

PHASE: NA

NCT ID: NCT06418204

Studying Cannabis to Improve Symptoms for People with Stage I-IV Breast Cancer

Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics Scientific Title

Purpose

To study the potential benefits and harms of cannabis products for cancer-related symptoms.

Who is this for?

People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are planning to receive or are receiving (within 2 months) treatment with chemotherapy, targeted therapy, and/or an immune checkpoint inhibitor (pembrolizumab (Keytruda®) or dostarlimab (Jemperli®)). You must be using cannabis products. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Surveys, at home or in person, monthly for 1 year</li> <li class="seamTextUnorderedListItem">Blood sample, 3 times in 1 year</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cannabis may help ease symptoms of cancer and side effects of treatment.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06418204' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 336 miles
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles,CA

VISITS: Number of visits unavailable

PHASE: II

NCT ID: NCT05595499

Fisetin to Improve Physical Function in Older Women After Chemotherapy

A Phase II Randomized Double-Blind Placebo-Controlled Study of Fisetin to Improve Physical Function in Frail Older Breast Cancer Survivors Scientific Title

Purpose

To study whether fisetin improves physical function in older women after treatment with chemotherapy.

Who is this for?

Women who were at least 65 years old and postmenopausal when diagnosed with stage I, stage II, or stage III breast cancer. You must have completed chemotherapy within the last year. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin, by mouth, 2 months</li> </ul> Group 2: Standard of Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for fisetin, by mouth, 2 months</li> </ul> Additional Procedures <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> <li class="seamTextUnorderedListItem">Walking test</li> <li class="seamTextUnorderedListItem">Grip strength test</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin is a naturally occurring substance that is found in strawberries and other foods.</li> <li class="seamTextUnorderedListItem">Fisetin eliminates cells that have stopped dividing but have not died.</li> <li class="seamTextUnorderedListItem">Chemotherapy causes a build-up of these cells which may cause inflammation. damage nearby healthy cells, and cause reduced physical function.</li> <li class="seamTextUnorderedListItem">Improving physical function is also called improving frailty.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05595499' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://restorativemedicine.org/digest/fisetin-powerful-polyphenol-supports-healthy-aging/' target='_blank'>Association for the Advancement of Restorative Medicine: Fisetin</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.urmc.rochester.edu/news/story/frailty-in-cancer-patients-young-and-old-is-linked-to-inflammation' target='_blank'>University of Rochester: Frailty and Breast Cancer</a> </li></ul>

NEAREST SITE: 336 miles
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles,CA

VISITS: Number of visits unavailable

PHASE: II

NCT ID: NCT06113016

Fisetin Supplement and Exercise to Improve Health After Treatment for Postmenopausal Women with Stage I-III Breast Cancer

A Phase II Randomized Placebo-Controlled Study of Fisetin and Exercise to Prevent Frailty in Breast Cancer Survivors (PROFFi) Scientific Title

Purpose

To study how well fisetin, a nutritional supplement, and exercise prevent frailty (weakness).

Who is this for?

Postmenopausal women with stage I, stage II, or stage III breast cancer who have received chemotherapy within the last year. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 4 groups: Group 1: Fisetin and Exercise Education Materials <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Handout on the importance of physical activity</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Fisetin and Exercise Program <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Supervised exercise training, 3 sessions every week for 4 months</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 3: Placebo and Exercise Program <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Supervised exercise training, 3 sessions every week for 4 months</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 4: Placebo and Exercise Education Materials <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Handout on the importance of physical activity</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Frailty is marked by low strength, low energy, slowed walking speed, low physical activity, and/or unintentional weight loss.</li> <li class="seamTextUnorderedListItem">In this study, frailty is measured by walking speed.</li> <li class="seamTextUnorderedListItem">Fisetin is a natural substance found in strawberries and other foods and is available as a nutritional supplement.</li> <li class="seamTextUnorderedListItem">Fisetin may help reduce inflammation and improve outcomes in people with breast cancer who are exercising.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06113016' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 336 miles
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles,CA

VISITS: 2 visits within 2 months

PHASE: II

NCT ID: NCT04290897

Oxaloacetate to Reduce Side Effects After Treatment in People with DCIS and Stage I-III Breast Cancer

A Phase II Single Arm Trial Evaluating the Safety and Efficacy of Anhydrous Enol-Oxaloacetate on Improving Cognitive Complaints in Breast Cancer Survivors Scientific Title

Purpose

To study the safety and ability of oxaloacetate to reduce brain problems, fatigue, sleep problems, and depression after breast cancer treatment.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or some stage III breast cancer who have completed treatment. You must have been diagnosed no more than 5 years ago. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Oxaloacetate, by mouth, daily for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Oxaloacetate is a natural substance found in the body and is available as a nutritional supplement.</li> <li class="seamTextUnorderedListItem">Oxaloacetate may reduce inflammation in the brain that could contribute to brain problems (cognition) after cancer treatments.</li> <li class="seamTextUnorderedListItem">Cognition is your ability to think.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04290897' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.gov/about-cancer/treatment/side-effects/memory#:~:text=Cancer%20treatments%20such%20as%20chemotherapy,during%20or%20after%20cancer%20treatment.' target='_blank'>National Cancer Institute: Memory or Concentration Problems and Cancer Treatment</a> </li></ul>

NEAREST SITE: 341 miles
Cedars-Sinai Medical Center
West Hollywood,CA

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT04722341

Time-Restricted Eating to Reduce Treatment Side Effects for People with Stage II-III Breast Cancer

Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators Scientific Title

Purpose

To study the effects (good and bad) and anti-cancer activity of time-restricted eating (TRE) during treatment before surgery.

Who is this for?

People with stage II or stage III breast cancer who are planning to receive chemotherapy before surgery (neoadjuvant). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Time-restricted eating (TRE) schedule, 8 hour daily eating period, 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Regular eating schedule, 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fasting may protect healthy cells from chemotherapy and radiation side effects.</li> <li class="seamTextUnorderedListItem">Time-restricted eating (TRE) involves eating within a period of 10 hours or less, followed by fasting for at least 14 hours daily.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04722341' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/research-news/can-fasting-reduce-recurrence-risk' target='_blank'>Breastcancer.org: Can Fasting 13 Hours or More at Night Reduce Recurrence Risk?</a> </li></ul>

NEAREST SITE: 348 miles
USC / Norris Comprehensive Cancer Center
Los Angeles,CA

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT06297265

Manual Breast Massage to Reduce Treatment Side Effects for Women with Stage 0-III Breast Cancer

Feasibility and Effects of Manual Lymphatic Drainage (MLD) Breast Massage in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy Scientific Title

Purpose

To study the ability of manual lymphatic drainage breast massage to reduce treatment related side effects.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have received a lumpectomy and are planning to receive radiation. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Manual lymphatic drainage breast massage, 2 times every week for 2-3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lumpectomy and radiation can lead to side effects including swelling called lymphedema, pain, reduced quality of life, and poor body image. </li> <li class="seamTextUnorderedListItem">Manual lymphatic drainage is a gentle massage technique used to reduce swelling. It may be a safe and effective way to reduce treatment related side effects after lumpectomy and radiation.</li> <li class="seamTextUnorderedListItem">Manual means you will be giving yourself the massage.</li> <li class="seamTextUnorderedListItem">Each massage is 30-60 minutes.</li> <li class="seamTextUnorderedListItem">You will be asked to complete the massage during radiation and for 1 month after radiation.</li> <li class="seamTextUnorderedListItem">A lumpectomy is sometimes called a partial mastectomy.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06297265' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 353 miles
City of Hope Medical Center
Duarte,CA

VISITS: 3 visits in 3 months

PHASE: II

NCT ID: NCT06538389

CBD for Joint Pain During Hormone Therapy for Women with Stage 0-III Breast Cancer

High Cannabidiol (CBD) Standardized Extract for Aromatase Inhibitor-Induced Arthralgia - A Randomized Controlled Double Blind Clinical Trial Scientific Title

Purpose

To study the ability of BC-001, a cannabidiol (CBD) plant extract, to reduce joint pain during hormone therapy.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or some stage III hormone receptor positive (ER+ and/or PR+) breast cancer who have completed treatment. You must be receiving an aromatase inhibitor and experiencing joint pain. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">BC-001, by mouth, daily, up to 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Placebo <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for BC-001, by mouth, daily, up to 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Women on aromatase inhibitor (AI) therapy may experience joint stiffness, pain and arthritis symptoms as a side effect of the medication.</li> <li class="seamTextUnorderedListItem">Some women stop AI therapy due to these side effects and do not receive the maximum benefit from the medication.</li> <li class="seamTextUnorderedListItem">BC-001 is an experimental cannabidiol (CBD) plant extract.</li> <li class="seamTextUnorderedListItem">CBD is derived from the same plant family as marijuana but is not associated with a <q>high</q> or mind-altering effect and is not habit-forming.</li> <li class="seamTextUnorderedListItem">CBD might decrease inflammation in joint tissues and may help reduce chronic pain.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06538389' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 533 miles
OHSU Knight Cancer Institute
Portland,OR

VISITS: 4 visits within 6 months

PHASE: II

NCT ID: NCT06049355

Exercise Program for Couples to Improve Physical and Mental Health During Radiation for Stage I-III Breast Cancer

EMBark on RAdiation Therapy With a Clinic-based Exercise Program: EXERCISING TOGETHER (EMBRACE) Scientific Title

Purpose

To study how well the Exercising Together program prevents declines in physical and mental health in couples where one partner is receiving radiation.

Who is this for?

People with stage I, stage II, or stage III breast cancer who are planning to receive or receiving radiation and live with a partner who is willing to participate in the study. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercising Together program, 6 months</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests, 4 times within 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 6 months</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Educational materials about exercise</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests, 4 times within 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Treatments for cancer including radiation can cause side effects such as fatigue and can put a strain on relationships. </li> <li class="seamTextUnorderedListItem">Exercising Together is an exercise program for both people in the relationship that adds communication, collaboration, and support to the exercise program and is designed to strengthen the relationship and increase the benefits of exercise. </li> <li class="seamTextUnorderedListItem">The Exercising Together program may improve the mental and physical health of couples when one person is receiving radiation treatment for cancer.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06049355' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 650 miles
Mayo Clinic in Arizona
Phoenix,AZ

VISITS: At least 2 visits within 6 months

PHASE: NA

NCT ID: NCT04816006

Exercise to Improve Thinking Ability After Treatment for Women with Stage I-III Breast Cancer

Enhancing Cognitive Function in Breast Cancer Survivors Through Community-based Exercise Training (BRAIN) Scientific Title

Purpose

To study whether an exercise program improves cognitive function (the ability to think).

Who is this for?

Postmenopausal women with stage I, stage II, or some stage III breast cancer who have completed treatment between 3 months ago and 2 years ago. You must regularly perform at least 20 minutes of exercise up to 2 days every week. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised exercise sessions, 20 sessions within 6 months</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Walking test</li> <li class="seamTextUnorderedListItem">Wear an accelerometer</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education sessions, in-person or virtual, monthly for 9 months</li> <li class="seamTextUnorderedListItem">Education resources and 1 year subscription to Mayo Clinic Health Letter</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Walking test</li> <li class="seamTextUnorderedListItem">Wear an accelerometer</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Free fitness center membership, 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Problems with thinking (cognition) affect daily functioning, quality of life, and long-term health. </li> <li class="seamTextUnorderedListItem">Aerobic exercise may help improve these problems and is generally considered safe, tolerable, and accessible.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, treadmill walking is the primary mode of exercise. However, you will be permitted to use other cardiovascular equipment (e.g., elliptical machines, stationary bicycles) as prescribed by your exercise trainer.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, the sessions will cover cancer support and discussion of cancer-related wellness topics such as stress management and coping.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will receive a free 6 month fitness membership after the study.</li> <li class="seamTextUnorderedListItem">An accelerometer is a device that measures how fast you walk.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04816006' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 682 miles
Fred Hutch/University of Washington Cancer Consortium
Seattle,WA

VISITS: At least 2 visits in 1 year

PHASE: NA

NCT ID: NCT05930483

Virtual Weight Loss Program for Latina Women After Treatment

Using a SMART Design to Evaluate Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors Scientific Title

Purpose

To study if a culturally appropriate weight loss program helps Latina breast cancer survivors lose weight.

Who is this for?

Hispanic/Latina women with stage I, stage II, or stage III breast cancer who were diagnosed within the last 5 years and have completed treatment (except hormone therapy). You must have a BMI >30. You must not smoke or have diabetes. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss and exercise program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> </ul> After 1 month, participants who do not achieve weight loss will be assigned to 1 of 3 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> <li class="seamTextUnorderedListItem">Personalized health coaching sessions, by phone, 14 sessions</li> </ul> Group 3 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> <li class="seamTextUnorderedListItem">Personalized health coaching sessions, by phone, 14 sessions</li> <li class="seamTextUnorderedListItem">Receive a bag of groceries, monthly</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Approximately 80% of Latinas in the United States are overweight, which can lead to poor breast cancer outcomes.</li> <li class="seamTextUnorderedListItem">A culturally appropriate program to promote and maintain weight loss in Latina breast cancer survivors is needed.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05930483' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 887 miles
Presbyterian Southern Outpatient Rehab
Rio Rancho,NM

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT05983380

Hand Exercises for Lymphedema for Women with Stage 0-III Breast Cancer

The Effect of Hand Mobility and Grip Strengthening Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors Scientific Title

Purpose

To determine if hand mobility and grip strengthening exercises with usual care will reduce swelling and improve quality of life, hand mobility, and grip strength.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who completed treatment in the past 10 years and have untreated lymphedema. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Hand exercises</li> <li class="seamTextUnorderedListItem">Compression, exercise, information about skin hygiene, and massage</li> <li class="seamTextUnorderedListItem">Measurements, 3 times within 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 2 months</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Compression, exercise, information about skin hygiene, and massage</li> <li class="seamTextUnorderedListItem">Measurements, 3 times within 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 2 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lymphedema is abnormal swelling in the arm, hand, breast, or torso that develops as a side effect of breast cancer treatments like surgery and radiation therapy.</li> <li class="seamTextUnorderedListItem">Lymphedema can affect arm function and quality of life.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05983380' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 941 miles
Outpatient CTRC
Aurora,CO

VISITS: 5 visits within 6 months

PHASE: I

NCT ID: NCT06430541

Psilocybin and Psychotherapy to Support Fear of Recurrence for Women with Stage I-II Breast Cancer

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission Scientific Title

Purpose

To study whether psilocybin and psychotherapy can reduce the fear of recurrence (cancer coming back).

Who is this for?

Women with stage I or stage II breast cancer who completed treatment at least 6 months ago. You must have a support person who agrees to take you home after receiving psilocybin. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Psilocybin, 1 time</li> <li class="seamTextUnorderedListItem">Psychotherapy, 4 times</li> <li class="seamTextUnorderedListItem">Surveys, 5 times within 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Psilocybin is a molecule found in psychedelic (magic) mushrooms.</li> <li class="seamTextUnorderedListItem">Psilocybin plus psychotherapy may reduce distress in people with cancer.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling other people with breast cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06430541' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://nyulangone.org/news/mental-health-benefits-one-dose-psychedelic-drug-last-years-people-cancer' target='_blank'>New York University Langone Health: Psilocybin and Mental Health in People with Cancer</a> </li></ul>

NEAREST SITE: 941 miles
University of Colorado Anschutz Medical Campus
Aurora,CO

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT06399276

Intermittent Fasting and Exercise to Increase Physical Activity for People with Stage I-III Breast Cancer

A Proof-of-Concept Study Evaluating a 4:3 Intermittent Fasting Weight Loss Intervention in Adults With Breast Cancer and Overweight or Obesity Scientific Title

Purpose

To study the ability of a lifestyle weight loss program to increase physical activity and decrease body weight.

Who is this for?

People 18 to 65 years old with stage I, stage II, or stage III breast cancer that was diagnosed in the last 10 years who completed treatment at least 3 months ago. You may currently be receiving hormone therapy. You must have a BMI of 25-45 kg/m2. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lifestyle weight loss program including intermittent fasting and exercise, in-person and virtual, 1 visit every week for 3 months</li> <li class="seamTextUnorderedListItem">Measurements of body weight and physical activity</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The weight loss program includes 3 fasting days every week and support to increase physical activity to 2.5 hours every week.</li> <li class="seamTextUnorderedListItem">Group support sessions will be held by an experienced Registered Dietician.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06399276' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 1455 miles
Sanford Worthington Medical Center
Worthington,MN

VISITS: Number of visits unavailable

PHASE: II

NCT ID: NCT06028022

Reishi Mushroom Extract for Fatigue and Pain for People with Stage 0-III Breast Cancer

Reishi Mushroom Extract for Fatigue and/or Arthralgias in Patients With Breast Cancer on Aromatase Inhibitors: A Randomized Phase II MNCCTN Trial Scientific Title

Purpose

To study the ability of Reishi mushroom extract to reduce fatigue, joint pain, and/or muscle pain.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III estrogen receptor positive (ER+) breast cancer who are receiving an aromatase inhibitor and experiencing fatigue. You must not be receiving a CDK4/6 inhibitor or olaparib (Lynparza®). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Reishi mushroom extract, by mouth, daily for the first month</li> <li class="seamTextUnorderedListItem">Placebo for Reishi mushroom extract, by mouth, daily for the second month</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for Reishi mushroom extract, by mouth, daily for the first month</li> <li class="seamTextUnorderedListItem">Reishi mushroom extract, by mouth, daily for the second month</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors are a type of hormone therapy commonly used to treat hormone receptor-positive breast cancer. The approved aromatase inhibitors are anastrozole (Arimidex®), letrozole (Femara®), and exemestane (Aromasin®).</li> <li class="seamTextUnorderedListItem">Side effects of aromatase inhibitors may include fatigue, joint pain, and/or muscle pain.</li> <li class="seamTextUnorderedListItem">Studies suggest that Reishi mushroom extract has beneficial effects including reducing fatigue.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06028022' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/hormonal-therapy/aromatase-inhibitors' target='_blank'>Breastcancer.org: Aromatase Inhibitors and Pain</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancercare.org/questions/11' target='_blank'>Cancer Care: Aromatase Inhibitors and Fatigue</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.healthline.com/nutrition/reishi-mushroom-benefits#TOC_TITLE_HDR_8' target='_blank'>Healthline: Reishi Mushroom Extract</a> </li></ul>

NEAREST SITE: 1643 miles
UT Health Houston
Houston,TX

VISITS: At least 2 visits within 1 year

PHASE: NA

NCT ID: NCT05349227

Virtual Health Coaching for People with Stage 0-IV Breast Cancer

Comprehensive Outcomes for After Cancer Health (COACH): The Feasibility and Impact of an mHealth Augmented Coaching Program for Self-Management in Cancer Survivors Scientific Title

Purpose

To study the use of virtual health coaching to improve well-being, including management of other health conditions, mental and social wellness, and healthy lifestyle behaviors.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer, and people without a history of breast cancer. If you have stage 0-III breast cancer, you must have completed treatment within the last year. If you have metastatic (stage IV) breast cancer, you must have been diagnosed with metastatic disease within the past year. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Immediately Start Coaching <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual health coaching, up to 4 times weekly, during first 6 months</li> <li class="seamTextUnorderedListItem">Provide stool samples, 2 times within 6 months</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires during second 6 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit, 1 year</li> </ul> Group 2: Delayed Start Coaching <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires during first 6 months</li> <li class="seamTextUnorderedListItem">Provide stool samples, 2 times within 6 months</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual health coaching, up to 4 times weekly, during second 6 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit, 1 year</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This program aims to support people's ability to manage their symptoms and their general wellness (including physical, mental, and social well-being, as well as following healthcare recommendations).</li> <li class="seamTextUnorderedListItem">Coaching consists of weekly calls and information about exercise, physical health, emotional health, and financial health.</li> <li class="seamTextUnorderedListItem">This study is also studying the relationship between symptoms and gut health and if coaching improves gut health.</li> <li class="seamTextUnorderedListItem">People that live in your household who do not have cancer will also be eligible to participate in this study.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05349227' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 1643 miles
M D Anderson Cancer Center
Houston,TX

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT05928325

Education and Support Program to Improve the Health of Older Adults with Stage I-III Breast Cancer

Implementation of a Geriatric Care Survivorship Intervention in Older Adults Who Have Completed Curative Intent Therapy for Early-Stage Breast Cancer Scientific Title

Purpose

To study the ability of an education and support survivorship program to improve the overall health of older adults who have completed breast cancer treatment.

Who is this for?

People at least 65 years old with stage I, stage II, or stage III breast cancer who are within 3 months of completing chemotherapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health assessments, 3 times within 1 year</li> <li class="seamTextUnorderedListItem">Education about survivorship</li> <li class="seamTextUnorderedListItem">Wearable device, 1 year</li> <li class="seamTextUnorderedListItem">Supportive therapy</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The health assessment asks about your physical, mental, and emotional health.</li> <li class="seamTextUnorderedListItem">Wearable devices such as FitBits are used to track your physical activity.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05928325' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.bcrf.org/blog/breast-cancer-elderly-treating-growing-patient-population/?psafe_param=1&utm_source=google&utm_medium=cpc&gclid=Cj0KCQjwuZGnBhD1ARIsACxbAVgxOj7KCm21Zmg5TCplhMCDhvola-e-h9IoQWD0A-pi9eLpEHWIIfgaAsz1EALw_wcB' target='_blank'>Breast Cancer Research Foundation: Older Adults and Breast Cancer</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mycarg.org/?page_id=437' target='_blank'>Cancer and Aging Resource Group: Improving the Care of Older Adults with Cancer</a> </li></ul>

NEAREST SITE: 1682 miles
University of Arkansas for Medical Science
Fayetteville,AR

VISITS: Up to 1 visit every week for 3 months

PHASE: NA

NCT ID: NCT06461416

Occupational Therapy to Improve Quality of Life for Stage 0-IV Breast Cancer

Occupational Resilience: A Pilot Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework Scientific Title

Purpose

To study whether an occupational therapy program helps people with breast cancer stay active and improve their quality of life.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer that was diagnosed within the last 6 months. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Occupational therapy, virtual and in-home sessions, weekly for 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual meetings, 1.5 hours, 3 times within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The occupational therapy program includes education on the benefits of activities and ways to continue participating in activities.</li> <li class="seamTextUnorderedListItem">These activities may include group physical exercise, healthy meal preparation, meditation, yoga, guided imagery, music (listening and/or performance), and dance.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with prostate cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06461416' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 1683 miles
The University of Texas Medical Branch, Galveston
Galveston,TX

VISITS: 2 visits in 3 months

PHASE: NA

NCT ID: NCT06395506

Exercise and Creatine Supplement to Increase Strength of Women After Chemotherapy

An Open-label Randomized Trial of Exercise ± Creatine Supplementation to Augment the Adaptations of Exercise Training in Cancer Survivors (THRIVE) Scientific Title

Purpose

To study if creatine supplements can help people with breast cancer respond more quickly to exercise and improve strength.

Who is this for?

Women with stage I, stage II, and stage III breast cancer who have completed chemotherapy in the last 6 months, and women who have not been diagnosed with breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Creatine and Exercise <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Creatine, by mouth, daily for 3 months</li> <li class="seamTextUnorderedListItem">Exercise sessions, virtual, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a Fitbit</li> <li class="seamTextUnorderedListItem">Strength and walking tests, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">DEXA scan, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times in 3 months</li> </ul> Group 2: Exercise Only <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise sessions, virtual, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a Fitbit</li> <li class="seamTextUnorderedListItem">Strength and walking tests, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">DEXA scan, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times in 3 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This study is comparing information from women who have never had breast cancer to women who have completed chemotherapy for breast cancer.</li> <li class="seamTextUnorderedListItem">Creatine is a supplement that may help you improve strength and physical function.</li> <li class="seamTextUnorderedListItem">A Fitbit is device you wear on your wrist that tracks your physical activity.</li> <li class="seamTextUnorderedListItem">DEXA scans use x-ray energy to measure bone density (thickness and strength of bones).</li> <li class="seamTextUnorderedListItem">A magnetic resonance imaging (MRI) scan produces body pictures created by using magnetic energy rather than x-ray energy.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06395506' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 1832 miles
Medical College of Wisconsin
Milwaukee,WI

VISITS: 3 visits in 1 year

PHASE: NA

NCT ID: NCT03824145

Every Day Counts Lifestyle Program to Improve Quality of Life for Women with Metastatic Breast Cancer

Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer Scientific Title

Purpose

To study whether the Every Day Counts lifestyle program improves the quality of life of women with metastatic breast cancer.

Who is this for?

Women with metastatic (stage IV) breast cancer that is currently stable and who live in Milwaukee, Wisconsin or Chicago, Illinois. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Every Day Counts lifestyle program, 4 months</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Home/work organization intervention, 4 months</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Every Day Counts lifestyle program</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Every Day Counts lifestyle program promotes nutritional and physical activity changes based on the American Cancer Society nutrition and physical activity guidelines.</li> <li class="seamTextUnorderedListItem">The Every Day Counts lifestyle program consists of: 1) a curriculum binder covering weekly topics and including self-monitoring tools to support adherence; 2) lifestyle coaching for 16-weeks, with in-person or virtual supervised exercise sessions and telephone-based sessions; 3) exercise supplies (Fitbit, resistance bands), 4) twice weekly text messaging targeting self-efficacy and social support; and 5) attendance to cooking classes emphasizing plant-based eating.</li> <li class="seamTextUnorderedListItem">The home/work organization intervention consists of: 1) a book with overview of home/work organization program with 16 weekly topics with an overview of each chapter, 2) virtual or weekly phone calls with a home organization coach with standard prompts, 3) text messages supporting home/work organization.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03824145' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://redcap.mcw.edu/surveys/?s=84MA4DRTTTA8FRCD' target='_blank'>Medical College of Wisconsin: Trial Information Brochure</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/healthy/eat-healthy-get-active/acs-guidelines-nutrition-physical-activity-cancer-prevention/guidelines.html' target='_blank'>American Cancer Society: Guideline for Diet and Physical Activity</a> </li></ul>

NEAREST SITE: 1832 miles
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee,WI

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT06106477

Intermittent Fasting to Improve Quality of Life for People with Stage I-III ER+, HER2- Breast Cancer

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer Scientific Title

Purpose

To study if intermittent fasting improves health-related quality of life.

Who is this for?

People with stage I, stage II, or stage III estrogen receptor positive (ER+ or ER low), HER2 negative (HER2- or HER2 low) breast cancer who are planning to receive hormone therapy after surgery (adjuvant). You must have a body mass index (BMI) of at least 25. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Intermittent fasting, daily, 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">In this trial, intermittent fasting (not eating) means that you are allowed to eat during a 10 hour period, with the last meal of the day between 5:00 PM and 9:00 PM.</li> <li class="seamTextUnorderedListItem">In this trial, HER2 low is defined as IHC 1+ or IHC 2+/FISH-.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06106477' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 1832 miles
Medical College of Wisconsin
Wauwatosa,WI

VISITS: At least 3 visits in 1 year

PHASE: NA

NCT ID: NCT05223322

Exercise to Reduce Side Effects During Treatment for Women with Stage I-III Breast Cancer

DECODE Heartland: Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction Scientific Title

Purpose

To study if exercise improves side effects caused by chemotherapy and anti-HER2 targeted therapy.

Who is this for?

Black/African American or non-Hispanic White women with stage I, stage II, or stage III breast cancer who are receiving chemotherapy with doxorubicin (Doxil®) or anti-HER2 targeted therapy with trastuzumab (Herceptin®), pertuzumab (Perjeta®), tucatinib (Tukysa®), neratinib (Nerlynx®), margetuximab (Margenza®), trastuzumab deruxtecan (Enhertu®, T-DXd), and/or trastuzumab emtansine (Kadcyla®, T-DM1). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, up to 2.5 hours every week for 4-5 months</li> <li class="seamTextUnorderedListItem">Exercise information, resistance bands, and activity tracker</li> <li class="seamTextUnorderedListItem">Physical tests, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Ultrasound, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Blood tests and biopsies, 3 times in 1 year</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supportive text messages, weekly</li> <li class="seamTextUnorderedListItem">Physical tests, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Ultrasound, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Blood tests and biopsies, 3 times in 1 year</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise information, resistance bands, and activity tracker (optional)</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some cancer medications such as chemotherapy and anti-HER2 targeted therapy may harm blood vessels.</li> <li class="seamTextUnorderedListItem">Harm to blood vessels may negatively affect physical health.</li> <li class="seamTextUnorderedListItem">Exercise may improve these negative effects.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05223322' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 1853 miles
University of Illinois Chicago
Chicago,IL

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT06504914

Healthy Cooking and Eating for Black Women with Stage 0-III Breast Cancer, High Blood Pressure, and Obesity

Developing FIM-BCS: A Lifestyle Modification for African-American Breast Cancer Survivors With Cardiovascular Risk Factors Scientific Title

Purpose

To study the ability of the Real Nourishment and Cooking Healthy Food is Rx program to improve nutritious eating habits and blood pressure control.

Who is this for?

Black and African American women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment. You must have high blood pressure, a BMI of at least 30, and live in Chicago, Illinois. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Real Nourishment and Cooking Healthy Food is Rx program, in person, 3 months</li> <li class="seamTextUnorderedListItem">Interviews and surveys, 3 times within 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High blood pressure and obesity are risk factors for heart disease.</li> <li class="seamTextUnorderedListItem">The Real Nourishment and Cooking Healthy Food is Rx program involves grocery delivery, cooking classes, and nutrition education and is designed to improve nutritious eating habits and blood pressure control.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06504914' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 1853 miles
University of Illinois Chicago
Chicago,IL

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT05259410

Time Restricted Eating During Chemotherapy for Women with Stage I-III Breast Cancer

The Safety and Efficacy of Time Restricted Eating Combined With Chemotherapy During Breast Cancer Treatment Scientific Title

Purpose

To study whether time restricted eating during chemotherapy improves treatment-related outcomes and quality of life and limits treatment-related side effects and weight gain.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy after surgery. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Time restricted eating, 3 months</li> </ul> Group 2: Standard of Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No time restricted eating, 3 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Time restricted eating, a form of intermittent fasting, is eating all food within the hours of 10:00am and 6:00pm, with water fasting the remaining hours of the day.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05259410' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/research-news/intermittent-fasting-may-help-cancer-treatments-work-better' target='_blank'>Breastcancer.org: Intermittent Fasting May Help Cancer Treatments Work Better</a> </li></ul>

NEAREST SITE: 1856 miles
Northwestern University
Chicago,IL

VISITS: 3 visits within 1 year

PHASE: NA

NCT ID: NCT06081127

Physical Therapy and Education Before Treatment for Women with Stage 0-IV Breast Cancer

A Randomized Pilot Test of the Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Functional Recovery (MOve-ABC) (B-PREPed) Scientific Title

Purpose

To study the ability of the Moving On After Breast Cancer (MOve-ABC) program to provide physical therapy and education before breast cancer treatment.

Who is this for?

Women with newly diagnosed stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer who have not yet received treatment. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Moving On After Breast Cancer (MOve-ABC) Program <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education about breast cancer side effects</li> <li class="seamTextUnorderedListItem">Physical therapy evaluation</li> <li class="seamTextUnorderedListItem">Home exercise program</li> <li class="seamTextUnorderedListItem">Phone calls and text messages</li> <li class="seamTextUnorderedListItem">Additional referrals (if needed)</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education on surgery recovery and pain management</li> <li class="seamTextUnorderedListItem">Additional referrals (if needed)</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Physical therapy before cancer treatment aims to help with early identification and self-management of treatment side effects.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06081127' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/exercise' target='_blank'>Breastcancer.org: Exercise and Breast Cancer</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cedars-sinai.org/health-library/diseases-and-conditions/p/physical-therapy---breast-cancer.html' target='_blank'>Cedars Sinai: Physical Therapy for Breast Cancer</a> </li></ul>

NEAREST SITE: 1946 miles
Indiana University
Indianapolis,IN

VISITS: 3 visits within 6 months

PHASE: NA

NCT ID: NCT04586530

Memory and Attention Training to Improve Cognition After Chemotherapy for Stage I-III Breast Cancer

Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial (TAMS) Scientific Title

Purpose

To determine if Memory and Attention Adaptation Training (MAAT) improves cognition (the ability to think).

Who is this for?

People with stage I, stage II, or stage III breast cancer who completed chemotherapy 1-5 years ago and have cognition (thinking and memory) problems. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Memory and Attention Adaptation Training (MAAT), virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires and memory tests, 3 times in 6 months</li> <li class="seamTextUnorderedListItem">Functional MRI scan, 2 times in 2 months (optional) </li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General support sessions, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires and memory tests, 3 times in 6 months</li> <li class="seamTextUnorderedListItem">Functional MRI scan, 2 times in 2 months (optional)</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Difficulty thinking, known as cognitive dysfunction or chemo brain, is common after chemotherapy.</li> <li class="seamTextUnorderedListItem">Memory and Attention Adaptation Training (MAAT) is a cognitive behavioral therapy (CBT) tool that increases self-awareness of situations in which memory problems occur, regulates emotion about memory problems, and helps people find strategies to improve daily memory tasks.</li> <li class="seamTextUnorderedListItem">This trial will use an advanced brain MRI technique called functional MRI (fMRI).</li> <li class="seamTextUnorderedListItem">fMRI measures changes in blood flow that happen during mental activity.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04586530' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2013 miles
University of Alabama at Birmingham
Birmingham,AL

VISITS: 3 visits per week for 2.5 months

PHASE: NA

NCT ID: NCT04088708

Impact of Exercise on Gut Microbiome and Fatigue After Treatment

Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors (ROME Study) Scientific Title

Purpose

To study if exercise changes the gut microbiome and fatigue levels.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment at least 1 year ago and are experiencing fatigue. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic exercise sessions with an instructor, 20-60 minutes, 3 times a week, 10 weeks</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Flexibility/toning exercise sessions with an instructor, 40 minutes, 3 times a week, 10 weeks</li> </ul> Additional Procedures <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires, 4 times</li> <li class="seamTextUnorderedListItem">Wearable device</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer survivors are at increased risk of gut bacteria communities (microbiome) that can negatively impact health and energy levels.</li> <li class="seamTextUnorderedListItem">Exercise may cause healthy changes in the gut microbiome.</li> <li class="seamTextUnorderedListItem">Fatigue (severe tiredness) is a common long-term side effect of breast cancer treatment.</li> <li class="seamTextUnorderedListItem">Aerobic exercise refers to cardiovascular exercise, which includes activities such as walking, running, biking, and swimming.</li> <li class="seamTextUnorderedListItem">Flexibility/toning activities will target the head/neck, shoulder, elbow/forearm, hand/wrist, trunk/hip, and ankle/foot.</li> <li class="seamTextUnorderedListItem">Wearable devices are used to track your physical activity outside of exercise sessions.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04088708' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.dana-farber.org/for-patients-and-families/for-survivors/caring-for-yourself-after-cancer/your-body-after-treatment/' target='_blank'>Dana-Farber Cancer Institute: Your Body After Treatment</a> </li><li class='seamTextUnorderedListItem'><a href='https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e22178' target='_blank'>ASCO Abstract: Gut Microbiome Alterations in Breast Cancer Survivors with Cancer-Related Fatigue</a> </li></ul>

NEAREST SITE: 2054 miles
University of Michigan
Ann Arbor,MI

VISITS: 1 visit

PHASE: NA

NCT ID: NCT06679400

Massage for Shoulder or Chest Pain for Women After Breast Cancer Treatment

Effects of Myofascial Massage and Patient-therapist Communication Levels on Shoulder Muscle Properties in Breast Cancer Survivors with Myofascial Pain Scientific Title

Purpose

To study if shoulder muscle massage can relieve shoulder muscle pain and how changes may be related to the amount of communication with the massage therapist.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment (except for long-term treatment taken by mouth) between 3 months and 2 years ago. You must have muscle pain in the upper part of your chest. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Shoulder and chest massage, 1 time</li> <li class="seamTextUnorderedListItem">More communication with the massage therapist</li> <li class="seamTextUnorderedListItem">Ultrasound scan, 2 times</li> <li class="seamTextUnorderedListItem">Surveys, 2 times</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Shoulder and chest massage, 1 time</li> <li class="seamTextUnorderedListItem">Less communication with the massage therapist</li> <li class="seamTextUnorderedListItem">Ultrasound scan, 2 times</li> <li class="seamTextUnorderedListItem">Surveys, 2 times</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Myofascial pain is muscle pain.</li> <li class="seamTextUnorderedListItem">Ultrasounds use sound waves to produce images of structures within your body without using radiation.</li> <li class="seamTextUnorderedListItem">The ultrasound scans will help see muscle changes before and after massage.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06679400' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2054 miles
University of Michigan
Ann Arbor,MI

VISITS: At least 3 visits within 6 months

PHASE: NA

NCT ID: NCT06100263

Supervised Exercise Program After Treatment for Black Women with Stage 0-III Breast Cancer

Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study Scientific Title

Purpose

To study how a supervised resistance exercise program affects the physical and social health of Black women after breast cancer treatment.

Who is this for?

Black, African American, and/or Afro-Latina women with stage 0 (DCIS), stage I, stage II, or some stage III breast cancer who have completed treatment within the last 5 years. You must exercise less than 2 times every week. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised resistance exercise program, 4 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Information about physical activity for people with cancer</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised exercise may improve a person's ability to exercise correctly, attitude about exercise, and physical and social health.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, each exercise session will be 35-45 minutes.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06100263' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2107 miles
Stephanie Spielman Comprehensive Breast Center
Columbus,OH

VISITS: 2 visits every week for 2 months

PHASE: NA

NCT ID: NCT05114005

Tango Dance Classes to Improve Nerve Pain After Chemotherapy for Stage I-III Breast Cancer

Novel Interventions for Chemotherapy-Induced Neuropathy Scientific Title

Purpose

To study whether Tango dance classes can improve nerve pain, posture, balance, and quality of life.

Who is this for?

People at least 40 years old with stage I, stage II, or stage III breast cancer who have completed chemotherapy at least 3 months ago. You must be experiencing nerve pain and posture issues. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Tango dance classes, 2 times every week for 2 months</li> <li class="seamTextUnorderedListItem">Assessment of balance and posture</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Home exercise, 2 times every week for 2 months</li> <li class="seamTextUnorderedListItem">Education about how to prevent falls and nerve pain</li> <li class="seamTextUnorderedListItem">Assessment of balance and posture</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Neuropathy is nerve pain in your hands and feet as a side effect of cancer treatment such as chemotherapy.</li> <li class="seamTextUnorderedListItem">Group dance classes can improve physical health.</li> <li class="seamTextUnorderedListItem">Because group dance classes are a social activity, they may also improve quality of life.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05114005' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.everydayhealth.com/fitness-pictures/health-benefits-of-dance.aspx' target='_blank'>Everyday Health: The Benefits of Dancing</a> </li></ul>

NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH

VISITS: 2 visits in 2.5 months

PHASE: NA

NCT ID: NCT05677802

Stress Management Therapy for Women with Stage I-III Triple Negative Breast Cancer

Examining the Feasibility of Implementing a Biobehavioral Stress Reduction Program in Triple Negative Breast Cancer Patients Scientific Title

Purpose

To study if stress management therapy reduces stress and addresses health-related social needs.

Who is this for?

Women with newly diagnosed stage I, stage II, or stage III triple negative (ER-, PR-, HER2-) breast cancer who have not yet received treatment. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Stress management therapy, 10 sessions in 2.5 months</li> <li class="seamTextUnorderedListItem">Blood tests, 2 times in 2.5 months</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The stress management therapy includes progressive muscle relaxation, coping, problem solving, communication, and social support.</li> <li class="seamTextUnorderedListItem">Health related social needs (such as utilities and transportation) will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05677802' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://breastcancernow.org/information-support/facing-breast-cancer/living-beyond-breast-cancer/life-after-breast-cancer-treatment/coping-emotionally/managing-stress-anxiety#:~:text=After%20a%20diagnosis%20of%20breast,and%20cope%20better%20with%20anxiety' target='_blank'>Breast Cancer Now: Coping with Stress Following a Breast Cancer Diagnosis</a> </li></ul>

NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH

VISITS: 7-9 visits within 3 months

PHASE: NA

NCT ID: NCT06635005

Low Insulin Diet to Reduce Breast Cancer Risk in High Risk Women

A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women Scientific Title

Purpose

To study whether a diet that leads to low insulin levels can reduce the risk of breast cancer.

Who is this for?

Women at least 45 years old or postmenopausal women with a BMI of 25-35 who are at high risk for breast cancer. You must receive care at the Ohio State University Comprehensive Cancer Center (OSUCCC) Stefanie Spielman Comprehensive Breast Center (SSCBC) high risk breast clinic. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nutrition education sessions, weekly for 1.5 months</li> <li class="seamTextUnorderedListItem">Nutrition counseling, in person or virtual, 3 times within 3 months</li> <li class="seamTextUnorderedListItem">Wear an activity tracker</li> <li class="seamTextUnorderedListItem">Blood, stool, and urine samples</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The diet in this study is designed to lower insulin levels.</li> <li class="seamTextUnorderedListItem">The diet is moderately low in total fat and saturated fat, low in protein from animal foods but high in protein from plant sources, high in fruits and vegetables, high in whole grains, and high in dietary fiber.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06635005' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH

VISITS: 8 visits within 9 months

PHASE: NA

NCT ID: NCT05984888

MIND Diet and Nutrition Counseling to Improve Brain Function for People with Stage II-IV HR+ Breast Cancer

Protecting the Brain From Toxic Side Effects of Chemotherapy: a Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer Scientific Title

Purpose

To study the impact of the Neurodegenerative Delay (MIND) diet on your cognition (ability to think).

Who is this for?

Postmenopausal women 45 to 75 years old with stage II, stage III, or stage IV (metastatic) hormone receptor positive (ER+ and/or PR+) breast cancer who are planning to begin treatment within 1 month. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nutrition counseling about the MIND diet, 8 in-person sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General health (non-diet) counseling, 8 in-person sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer treatment can lead to cognition (ability to think) problems and low quality of life.</li> <li class="seamTextUnorderedListItem">The Neurodegenerative Delay (MIND) diet is high in anti-inflammatory nutrients (omega-3, carotenoids, B vitamins, etc.) and limits foods that are not healthy for the brain (butter, cheese, red meat, fried foods, sugar, etc.).</li> <li class="seamTextUnorderedListItem">The MIND diet may help improve brain function during cancer treatment.</li> <li class="seamTextUnorderedListItem">Cognition is your ability to think.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05984888' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://health.osu.edu/wellness/exercise-and-nutrition/the-mind-diet' target='_blank'>Ohio State University: The MIND Diet and Brain Health</a> </li><li class='seamTextUnorderedListItem'><a href='https://my.clevelandclinic.org/health/diseases/21032-chemo-brain' target='_blank'>Cleveland Clinic: Chemotherapy and Brain Function Problems</a> </li></ul>

NEAREST SITE: 2108 miles
The Ohio State University
Columbus,OH

VISITS: 3 visits every week for 4 months

PHASE: NA

NCT ID: NCT05193149

Training to Strengthen Breathing Muscles and Exercise Program After Treatment for Overweight Women with Stage 0-III Breast Cancer

Reducing Exercise Intolerance Through Inspiratory Muscle Training in Obese Breast Cancer (IMOCS) Scientific Title

Purpose

To study the ability of training to strengthen breathing muscles to improve the ability to exercise.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who completed treatment between 6 months to 5 years ago. You must have a BMI of at least 30 kg/m2 and exercise less than 1.5 hours every week. You may still be receiving hormone therapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Training to strengthen breathing muscles, 3 times every week for 1 month</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic exercise training, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Exercise, strength, and fatigue tests</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo training to strengthen breathing muscles, 3 times every week for 1 month</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic exercise training, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Exercise, strength, and fatigue tests</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Training to strengthen the muscles used for breathing may improve the ability to exercise.</li> <li class="seamTextUnorderedListItem">Aerobic exercise includes cycling, walking, and using the elliptical.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05193149' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.lung.org/lung-health-diseases/wellness/breathing-exercises' target='_blank'>American Lung Association: Breathing Exercises to Strengthen Breathing Muscles</a> </li></ul>

NEAREST SITE: 2136 miles
Grady Health System
Atlanta,GA

VISITS: Up to 1-2 visits every week for 3 months

PHASE: NA

NCT ID: NCT06534125

Acupuncture or Acupressure to Prevent Joint Pain from Hormone Therapy for Postmenopausal Non-Hispanic Black Women with Stage I-III HR+, HER2- Breast Cancer

Preventing Aromatase Inhibitor-Associated Arthralgias Among Non-Hispanic Black Postmenopausal Women with Early-Stage Breast Cancer Scientific Title

Purpose

To compare the ability of in-person acupuncture and at-home acupressure to prevent joint pain from hormone therapy.

Who is this for?

Postmenopausal non-Hispanic Black women with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+), HER2 negative (HER2-) breast cancer who completed treatment at least 2 weeks ago and are planning to receive letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®) aromatase inhibitor. You must not have received or be currently receiving palbociclib (Ibrance®), ribociclib (Kisqali®), or abemaciclib (Verzenio®) CDK4/6 inhibitor. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Acupuncture, in person, every 1-2 weeks for 3 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Acupressure, at home, every 1-2 weeks for 3 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> Group 3: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No acupuncture or acupressure</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors prolong life in postmenopausal women with HR+ breast cancer.</li> <li class="seamTextUnorderedListItem">However, non-Hispanic Black women are more likely to experience side effects such as joint pain and stop their hormone therapy compared to non-Hispanic white women.</li> <li class="seamTextUnorderedListItem">Acupuncture involves inserting thin needles through the skin at specific points on the body to control pain.</li> <li class="seamTextUnorderedListItem">Acupressure uses the application of pressure or localized massage to specific sites on the body to control symptoms such as pain.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06534125' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2137 miles
Emory University Hospital Midtown
Atlanta,GA

VISITS: 1 visit every day for 2 weeks

PHASE: NA

NCT ID: NCT05368428

Transcutaneous Electrical Nerve Stimulation for Chemotherapy Induced Peripheral Neuropathy in People with Stage I-III Breast Cancer

Single-Institution Trial Investigating the Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in Taxane Induced Peripheral Neuropathy (CIPN) in Patients With Early Stage Breast Cancer Scientific Title

Purpose

To determine if transcutaneous electrical nerve stimulation (TENS) reduces chemotherapy induced peripheral neuropathy (CIPN).

Who is this for?

People with stage I, stage II, or stage III breast cancer who are receiving chemotherapy and have chemotherapy induced peripheral neuropathy (CIPN). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Transcutaneous electrical nerve stimulation (TENS), daily for 2 weeks</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Chemotherapy induced peripheral neuropathy (CIPN) is nerve pain in your hands and feet as a side effect of chemotherapy.</li> <li class="seamTextUnorderedListItem">Neuropathy is pain from nerve damage.</li> <li class="seamTextUnorderedListItem">Transcutaneous electrical nerve stimulation (TENS) involves mild electric currents applied to some areas of your skin to potentially improve neuropathy.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05368428' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://my.clevelandclinic.org/health/treatments/15840-transcutaneous-electrical-nerve-stimulation-tens' target='_blank'>Cleveland Clinic: Transcutaneous Electrical Nerve Stimulation (TENS)</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/neuropathy' target='_blank'>Breastcancer.org: Neuropathy</a> </li></ul>

NEAREST SITE: 2168 miles
Case Western Reserve University/University Hospitals Cleveland
Cleveland,OH

VISITS: At least 2 visits within 2-7 months

PHASE: NA

NCT ID: NCT05535192

Exercise and Nutrition Support During Chemotherapy for Older Women with Stage I-III Breast Cancer

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients (THRIVE-65) Scientific Title

Purpose

To study if exercise plus support to increase protein intake will make it easier for older women to receive chemotherapy as prescribed.

Who is this for?

Women at least 65 years old with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Exercise and Nutrition Support <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, 1 session in person, then 2 sessions at home every week during chemotherapy</li> <li class="seamTextUnorderedListItem">Meeting with dietician, virtual</li> <li class="seamTextUnorderedListItem">Diet journal</li> <li class="seamTextUnorderedListItem">Body and memory tests, 2 times</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Health Education <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health educational materials on tablet during chemotherapy appointments</li> <li class="seamTextUnorderedListItem">Body and memory tests, 2 times</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">If you are in Group 1, you will work with an exercise coach to perform muscle strengthening exercises and aerobic exercises. </li> <li class="seamTextUnorderedListItem">If you are in Group 1, you will also meet with a dietitian to make sure you are eating enough protein during chemotherapy. You will keep a daily protein checklist and share this with the exercise coach each week.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will receive a tablet with information about meditation, stretching and gentle movement, relaxation, and creative arts during chemotherapy appointments.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05535192' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2260 miles
Allegheny General Hospital
Pittsburgh,PA

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT06858449

Exercise Program and Protein Supplement to Improve Strength During Chemotherapy for Women with Stage I-III Breast Cancer

NeoChemoPRT: a Randomized Study of Resistance Training and Post-Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer Scientific Title

Purpose

To study if an exercise program and high dose of protein supplement will improve body composition and strength for people receiving chemotherapy before surgery (neoadjuvant).

Who is this for?

Women with stage I, stage II, or some stage III breast cancer who are planning to receive chemotherapy before surgery (neoadjuvant). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Exercise with Low Dose of Protein <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistance (strength) exercise program, 6 months</li> <li class="seamTextUnorderedListItem">20 grams of protein supplement, after each exercise session</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Exercise with High Dose of Protein <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistance (strength) exercise program, 6 months</li> <li class="seamTextUnorderedListItem">60 grams of protein supplement, after each exercise session</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistence training is a type of exercise aimed at improving muscular strength and endurance.</li> <li class="seamTextUnorderedListItem">Protein supplements can help your body build muscle.</li> <li class="seamTextUnorderedListItem">In this study, the protein is made of whey, which is a dairy product.</li> <li class="seamTextUnorderedListItem">The whey is non-GMO, grass-fed, soy and gluten free, unflavored, and unsweetened.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06858449' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2260 miles
Allegheny General Hospital
Pittsburgh,PA

VISITS: 3 times per week for 3 months

PHASE: NA

NCT ID: NCT06115486

Exercise to Improve Muscle Mass After Treatment for Stage 0-III Breast Cancer

EXERT-BCH: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer to Improve Hypertrophy Scientific Title

Purpose

To compare the ability of 2 group exercise programs to increase muscle mass for women after breast cancer treatment.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Standard of Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistance training in a small group, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Strength measurements</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Strength and conditioning training in a small group, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Strength measurements</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise to build muscle mass in people who have been treated for breast cancer may reduce toxicity from treatment, increase time to tumor progression, and prolong survival.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06115486' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2299 miles
Roswell Park Cancer Institute
Buffalo,NY

VISITS: 1 visit

PHASE: NA

NCT ID: NCT06456411

Brain Scan and Virtual Reality to Decrease Pain for People with Stage 0-IV Breast Cancer

Real-Time Evaluation of Severity of Perceived Pain in Patients With Cancer by Using Functional Near-Infrared Spectroscopy (fNIRS), and Investigation of Pain Relief Utilizing Virtual Reality Technologies Scientific Title

Purpose

To study whether a virtual reality relaxation program can decrease pain and if this can be seen in the brain with a functional near-infrared spectroscopy scan.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are experiencing pain from treatment, and people who do not have breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Virtual Reality and Scan <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Functional near-infrared spectroscopy scan, 1 time</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual reality, 1 time, at least 15 minutes</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Scan Only <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Functional near-infrared spectroscopy scan, 1 time</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Functional near-infrared spectroscopy is a non-invasive type of imaging scan that can show pictures of the brain and brain activity.</li> <li class="seamTextUnorderedListItem">Virtual reality (VR) is a computer-generated experience that simulates the 3D environment.</li> <li class="seamTextUnorderedListItem">Virtual reality relaxation programs may help relieve pain in people with cancer who are receiving treatment. Relief of pain may be seen on a functional near-infrared spectroscopy scan.</li> <li class="seamTextUnorderedListItem">Results from people who do not have breast cancer will be compared to results from people with breast cancer.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06456411' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.techtarget.com/whatis/definition/virtual-reality' target='_blank'>Tech Target: What is Virtual Reality?</a> </li></ul>

NEAREST SITE: 2314 miles
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem,NC

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT05595577

Exercise to Improve Heart and Brain Function for Stage I-III Breast Cancer

Improving Exercise Capacity With a Tailored Physical Activity Intervention in Lymphoma and Breast Cancer Patients Undergoing Treatment (PALS) Scientific Title

Purpose

To study if an exercise program helps improve exercise capability, heart function, memory, and quality of life compared to health classes.

Who is this for?

People with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy, trastuzumab (Herceptin®), immunotherapy, or radiation. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, 1-2 sessions every week for 6 months</li> <li class="seamTextUnorderedListItem">Heart tests, 2 times</li> <li class="seamTextUnorderedListItem">Heart MRI scan</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health classes, virtual or in person, 12 sessions within 6 months</li> <li class="seamTextUnorderedListItem">Heart tests, 2 times</li> <li class="seamTextUnorderedListItem">Heart MRI scan</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some cancer treatments can harm the heart.</li> <li class="seamTextUnorderedListItem">Exercise may improve heart and brain function and improve quality of life.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, the exercise sessions include an aerobic warm-up, strength training, aerobic exercise of increasing intensity, and cool-down with elastic bands.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, the control health classes provide information about nutrition, stress management, sleep, and a healthy lifestyle.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05595577' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2354 miles
Integrative Cardiovasculal Physiology Laboratory, University of Florida
Gainesville,FL

VISITS: 3 visits every week for 3 months

PHASE: NA

NCT ID: NCT05848141

Rowing for Heart Health After Treatment for Women with Stage I-III Breast Cancer

Indoor Rowing as a Novel Exercise Therapy for Cardiovascular Rehabilitation in Middle-Aged and Older Breast Cancer Survivors Following Chemotherapy Scientific Title

Purpose

To study how rowing exercise affects heart health for breast cancer survivors.

Who is this for?

Women 40 to 80 years old with stage I, stage II, or stage III breast cancer who completed primary treatment between 6 months and 2 years ago. You must not have heart disease. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise with indoor rowing machine after study completion (optional)</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise with indoor rowing machine, 3 days every week for 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">People who have received chemotherapy and some other types of breast cancer treatment have a higher risk for heart disease that people who have not.</li> <li class="seamTextUnorderedListItem">Exercise may decrease the risk of heart disease.</li> <li class="seamTextUnorderedListItem">Each rowing exercise is about 50 minutes.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05848141' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2354 miles
Integrative Cardiovascular Physiology Laboratory, University of Florida
Gainesville,FL

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT05913713

Exercise for Heart Health After Chemotherapy for Women with Stage I-III Breast Cancer

High Intensity Interval Training: Optimizing Exercise Therapy to Mitigate Cardiovascular Disease Risk Following Breast Cancer Chemotherapy Scientific Title

Purpose

To study the ability of high intensity or moderate intensity exercise to improve heart health after chemotherapy.

Who is this for?

Women 18 to 85 years old with stage I, stage II, or stage III breast cancer who completed chemotherapy between 6 months and 1.5 years ago. You must currently exercise less than 2.5 hours every week. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High intensity exercise using a stationary bike, at home, 3 days every week for 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Moderate intensity exercise using a stationary bike, at home, 3 days every week for 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> Group 3: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Continue routine exercise, 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High or moderate intensity exercise using a stationary bike, at home, 3 days every week for 3 months (optional)</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">People who have received chemotherapy have a higher risk for heart disease that people who have not received chemotherapy.</li> <li class="seamTextUnorderedListItem">Exercise may decrease the risk of heart disease.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05913713' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2354 miles
Integrative Cardiovasculal Physiology Laboratory, University of Florida
Gainesville,FL

VISITS: At least 1 visit

PHASE: NA

NCT ID: NCT04914663

Exercise to Reduce Heart Problems During Chemotherapy for Women with Stage I-III Breast Cancer

All-extremity Exercise as a Novel Strategy for Optimizing Cardiovascular Function During Chemotherapy for Breast Cancer Scientific Title

Purpose

To study if 2 different types of exercise reduce heart problems during chemotherapy.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy. You must not be receiving a CDK4/6 inhibitor, PARP inhibitor, or radiation during chemotherapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Full body exercise, at home, 3 months</li> <li class="seamTextUnorderedListItem">Physical function tests</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Treadmill exercise, at home, 3 months</li> <li class="seamTextUnorderedListItem">Physical function tests</li> </ul> Group 3: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Physical function tests</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments, such as chemotherapy, can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">Exercise may help reduce these heart problems.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04914663' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2354 miles
Institute on Aging; University of Florida
Gainesville,FL

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT05684367

Walking to Reduce Fatigue for Older Women After Treatment

Center-Based and Home-Based Walking Exercise Intervention to Reduce Fatigue in Older Breast Cancer Survivors (EXERGISE) Scientific Title

Purpose

To study if walking can reduce fatigue.

Who is this for?

Women at least 60 years old with stage I, stage II, or stage III breast cancer who completed treatment between 3 months and 1 year ago. You must be experiencing fatigue (feeling tired). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Walking at research center, 30 minutes per session, 3 days every week for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Walking at home, 30 minutes per session, 5 days every week for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Many people experience fatigue (feeling tired) after cancer treatment.</li> <li class="seamTextUnorderedListItem">Older breast cancer survivors experience more fatigue than younger survivors.</li> <li class="seamTextUnorderedListItem">Aerobic exercise (such as walking) can improve fatigue in younger breast cancer survivors, but these effects are not as strong in older people. New methods are needed to reduce fatigue in older breast cancer survivors.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05684367' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2383 miles
Mayo Clinic in Florida
Jacksonville,FL

VISITS: 3 visits within 1 year

PHASE: NA

NCT ID: NCT06106282

Reducing Bone and Joint Problems During Hormone Therapy for Women with Stage 0-III Breast Cancer

Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS): A Multidisciplinary Pain Program Designed to Decrease Pain and Improve Functioning, Mood, and Medication Adherence. (AIMSS) Scientific Title

Purpose

To study a behavioral program designed to reduce pain, improve mood, improve functioning, and improve the ability to take medication as recommended.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who have been receiving an aromatase inhibitor for between 6 months and 7 years. You must be experiencing bone or joint problems and be receiving your care at Mayo Clinic in Jacksonville, Florida. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Behavioral program, in person, for 2 days</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Anastrozole (Arimidex®), letrozole (Femara®), and exemestane (Aromasin®) are types of hormone therapy called aromatase inhibitors. Aromatase inhibitors block some production of estrogen that helps cancer grow.</li> <li class="seamTextUnorderedListItem">These drugs may cause bone problems or joint pain or stiffness as side effects.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06106282' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/hormonal-therapy/aromatase-inhibitors' target='_blank'>Breastcancer.org: Aromatase Inhibitors</a> </li></ul>

NEAREST SITE: 2388 miles
Duke Cancer Network
Durham,NC

VISITS: 3 visits in 4 months

PHASE: NA

NCT ID: NCT06555588

ENGAGE Telehealth Program to Reduce Symptoms and Improve Quality of Life for People with Metastatic Breast Cancer

Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients With Advanced Cancer Scientific Title

Purpose

To study the ability of ENGAGE, a telehealth program, to reduce pain, fatigue, and distress and improve quality of life for people with metastatic breast cancer.

Who is this for?

People with metastatic (stage IV) breast cancer who are experiencing pain, fatigue, and/or distress. You must be receiving care at a Duke Cancer Network (DCN) clinic. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">ENGAGE program, virtual, 4 sessions</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 4 months</li> </ul> Group 2: Supportive Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supportive care program, virtual, 4 sessions</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 4 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">ENGAGE sessions use Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) approaches to manage pain, fatigue, and distress.</li> <li class="seamTextUnorderedListItem">Supportive care sessions focus on education, support, and resources focused on common cancer-related concerns, such as education on symptoms, body image concerns, and financial concerns.</li> <li class="seamTextUnorderedListItem">All sessions (Group 1 and Group 2) are led by trained therapists and are 45-60 minutes long.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06555588' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.nami.org/treatment/how-i-use-act-and-cbt-to-help-people-cope-with-health-conditions/' target='_blank'>National Alliance on Mental Illness: Using ACT and CBT to Help People Cope with Health Conditions</a> </li></ul>

NEAREST SITE: 2433 miles
Sibley Memorial Hospital
Washington,DC

VISITS: 4 visits within 1 year 2 months

PHASE: NA

NCT ID: NCT05780814

Improving Sleep Problems and Weight Loss for Women After Treatment

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer (COIN) Scientific Title

Purpose

To study the ability of a cognitive behavioral therapy (CBT) program to improve sleep problems before losing weight.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who were diagnosed within the last 10 years and have completed treatment (except hormone therapy). You must also be overweight (BMI > 25), planning to lose weight, and experiencing sleep problems. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cognitive behavioral therapy (CBT) sessions to improve sleep, virtual, 6 times within 2 months</li> <li class="seamTextUnorderedListItem">Videos about weight loss, 19 videos</li> <li class="seamTextUnorderedListItem">Electronic sleep diary, 1 week</li> <li class="seamTextUnorderedListItem">Body measurements, 4 times</li> <li class="seamTextUnorderedListItem">DEXA scans, 2 times</li> <li class="seamTextUnorderedListItem">Smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires, 5 times</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education sessions about sleep and cancer, virtual, 6 times within 2 months</li> <li class="seamTextUnorderedListItem">Body measurements, 4 times</li> <li class="seamTextUnorderedListItem">DEXA scans, 2 times</li> <li class="seamTextUnorderedListItem">Smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires, 5 times</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The cognitive behavioral therapy (CBT) program combines education and behavioral techniques to reduce sleep problems (insomnia).</li> <li class="seamTextUnorderedListItem">Cognitive behavioral therapy (CBT) is a type of therapy that focuses on the relationship between thoughts, feelings, and behaviors.</li> <li class="seamTextUnorderedListItem">All participants will follow a program with the goals of increasing physical activity, improving diet, and losing weight.</li> <li class="seamTextUnorderedListItem">Wearable devices such as smart watches and FitBits are used to track your physical activity.</li> <li class="seamTextUnorderedListItem">A DEXA scan measures fat, muscle, and bone density.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05780814' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2433 miles
Sibley Memorial Hospital
Washington,DC

VISITS: 1 visit every week for 1 month

PHASE: NA

NCT ID: NCT06536881

Fasting to Improve Adherence to Chemotherapy for Women with Stage I-III Breast Cancer

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming (GAMMER) Study in Early Stage Breast Cancer Receiving Chemotherapy Scientific Title

Purpose

To study if fasting (not eating) for 1-2 days during chemotherapy helps women continue receiving chemotherapy as prescribed.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who are planning to receive one of the following chemotherapy treatments: dose dense doxorubicin (Doxil®) and cyclophosphamide (Cytoxan®) (called ddAC) or docetaxel (Taxotere®) and cyclophosphamide (Cytoxan®) (called TC). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fast (not eat, except for water) for 1-2 days during chemotherapy</li> <li class="seamTextUnorderedListItem">Stool (poop) samples, weekly for 3 weeks</li> <li class="seamTextUnorderedListItem">Blood samples, weekly for 1 month</li> <li class="seamTextUnorderedListItem">Questionnaires, weekly for 1 month</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Previous research suggests that fasting during chemotherapy is safe and can prevent some toxic effects of chemotherapy without causing chronic weight loss.</li> <li class="seamTextUnorderedListItem">Fasting may allow people to experience less issues during chemotherapy (tolerance) and receive chemotherapy as prescribed (adherence).</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06536881' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2437 miles
AdventHealth
Orlando,FL

VISITS: 4 visits within 6 months

PHASE: NA

NCT ID: NCT06078761

Healthy Eating and Active Lifestyle (HEAL) Education Program to Prevent Breast Cancer Recurrence

A Prospective Study of the Healthy Eating and Active Lifestyle (HEAL BC): Breast Cancer Program on Survivorship Outcomes Scientific Title

Purpose

To study the impact of the Healthy Eating and Active Lifestyle (HEAL) program on recurrence (cancer coming back), stress, body measurements, lifestyle behaviors, mental health, and quality of life.

Who is this for?

People with stage I, stage II, or stage III breast cancer who have completed treatment and receive care at AdventHealth Medical Group in Orlando, FL. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">HEAL education sessions, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Weight and blood pressure measurements, 4 times within 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Healthy Eating and Active Lifestyle (HEAL) program is a lifestyle program for cancer survivors with the goal of decreasing risk of cancer recurrence (cancer coming back) and preventing, treating, and potentially reversing other long-term diseases.</li> <li class="seamTextUnorderedListItem">The program includes plant-based nutrition, yoga, and mindfulness.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06078761' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.adventhealthcancerinstitute.com/HEALBreast' target='_blank'>AdventHealth: HEAL Breast Cancer Program</a> </li></ul>

NEAREST SITE: 2531 miles
Virtua Health
Voorhees,NJ

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT05704842

Exercise to Reduce Fatigue During Chemotherapy for Women with Stage I-III Breast Cancer

Pilot Study to Evaluate the Impact of a Home-Based Exercise Program on Cancer-Related Fatigue in Breast Cancer Patients Undergoing Curative-Intent Chemotherapy Scientific Title

Purpose

To study if exercise reduces fatigue during treatment with chemotherapy.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who plan to receive chemotherapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visit with physical therapist</li> <li class="seamTextUnorderedListItem">Complete home-based exercise program</li> <li class="seamTextUnorderedListItem">Complete online surveys, weekly</li> </ul> Group 2: Standard Treatment <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Complete online surveys, weekly</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The home-based exercise program includes exercises such as: core stabilization, core extension, leg extensions, squats with and without weights, shoulder exercises, and arm exercises.</li> <li class="seamTextUnorderedListItem">The online surveys will assess your symptoms and fatigue.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05704842' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/fatigue' target='_blank'>Breastcancer.org: Cancer Fatigue</a> </li></ul>

NEAREST SITE: 2539 miles
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge,NJ

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT04589468

Walking Exercise to Prevent Breast Cancer From Coming Back

Phase 1a/b Trial of Exercise as Interception Therapy for Primary High-Risk Cancer Scientific Title

Purpose

To study if exercise reduces the level of circulating tumor DNA (ctDNA) in the blood and reduces the risk of breast cancer coming back.

Who is this for?

People with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+), HER2 negative (HER2-) breast cancer who completed treatment within the last 2 years and are at high risk of cancer coming back (recurrence). You must exercise less than 1 hour every week. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will complete the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Walking aerobic exercise, 3-6 times every week for up to 1.5 years</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High risk of cancer coming back (recurrence) is defined as the presence of cancer after completing neoadjuvant (before surgery) treatment. This is called residual disease.</li> <li class="seamTextUnorderedListItem">Circulating tumor DNA (ctDNA) are small bits of cancer cell DNA that specific tests can find in the bloodstream.</li> <li class="seamTextUnorderedListItem">ctDNA in the blood may be related to cancer coming back.</li> <li class="seamTextUnorderedListItem">Aerobic exercise stimulates and strengthens the heart and lungs and improves the body's use of oxygen.</li> <li class="seamTextUnorderedListItem">This study is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04589468' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2539 miles
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge,NJ

VISITS: Number of visits unavailable

PHASE: III

NCT ID: NCT06144164

Managing Lymphedema After Lymph Node Surgery for Women with Stage I-III Breast Cancer

A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: The Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life Scientific Title

Purpose

To study the ability of a lymphedema prevention program to help lymph fluid drain out of the arm, prevent lymphedema, and improve quality of life.

Who is this for?

Women 18-75 years old with stage I, stage II, or stage III breast cancer who are planning to receive axillary lymph node dissection or sentinel lymph node biopsy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Immediate lymphatic reconstruction (ILR) during lymph node surgery</li> <li class="seamTextUnorderedListItem">Lymphatic massage, at home, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Compression garments, daily for 3 months</li> <li class="seamTextUnorderedListItem">Arm measurements, up to 2 years</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lymphedema is the build up of fluid and abnormal swelling of the arm (in the case of axillary lymph node dissection or sentinel lymph node biopsy surgery).</li> <li class="seamTextUnorderedListItem">Lymphedema is caused by damage to the lymphatic system and inability to drain excess lymph fluid.</li> <li class="seamTextUnorderedListItem">Immediate Lymphatic Reconstruction (ILR) is a procedure to rebuild damaged lymphatic system.</li> <li class="seamTextUnorderedListItem">Lymphatic massage may help reduce swelling in your body.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06144164' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mskcc.org/cancer-care/patient-education/about-your-immediate-lymphatic-reconstruction-ilr-procedure#:~:text=ILR%20is%20a%20procedure%20to,your%20axillary%20lymph%20node%20dissection.' target='_blank'>Memorial Sloan Kettering Cancer Center: About Your Immediate Lymphatic Reconstruction (ILR) Procedure</a> </li></ul>

NEAREST SITE: 2567 miles
Memorial Sloan Kettering Cancer Center
New York,NY

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT04458532

Aerobic Exercise to Improve Cardiovascular Health in Post-Menopausal Women After Breast Cancer Treatment

A Randomized Trial to Minimize Non-Response to Aerobic Training in Post-Menopausal Women With Early Stage Breast Cancer Scientific Title

Purpose

To study how different amounts of aerobic exercise improves cardiovascular health after breast cancer treatment.

Who is this for?

Postmenopausal women with stage I, stage II, or stage III breast cancer who have completed treatment with surgery and radiation, chemotherapy, or trastuzumab (Herceptin®) within the past 1-5 years. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 4 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 5 hours/week for 4 months</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 2.5 hours/week for 8 months</li> </ul> Group 3 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 5 hours/week for 8 months</li> </ul> Group 4 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 2.5 hours/week for 4 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic exercise is physical activity of light-to-moderate intensity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for at least 10 minutes.</li> <li class="seamTextUnorderedListItem">The researchers will study the effects of different exercise programs on your cardiovascular health, which is how well your body uses oxygen, how well your heart pumps blood, how well your lungs function, and how healthy your blood vessels are.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04458532' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/exercise' target='_blank'>Breastcancer.org: Exercise</a> </li></ul>

NEAREST SITE: 2567 miles
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York,NY

VISITS: 10 visits in 2.5 months

PHASE: NA

NCT ID: NCT06814977

Acupuncture for Joint Pain for Hispanic or Black Women with Stage I-III Breast Cancer

Researching the Implementation of Acupuncture for Aromatase Inhibitor-related Arthralgias in Diverse Underserved Breast Cancer Survivors (ReIMAGINE) Scientific Title

Purpose

To study whether acupuncture can treat joint pain caused by hormone therapy.

Who is this for?

Black or Hispanic women or transgender males, with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who have completed primary treatment at least 1 month ago and are receiving an aromatase inhibitor. You must be experiencing joint pain. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Acupuncture, weekly for 2.5 months</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors are letrozole (Femara®), anastrozole (Arimidex®), and exemestane (Aromasin®).</li> <li class="seamTextUnorderedListItem">Aromatase inhibitors can cause pain such as joint pain.</li> <li class="seamTextUnorderedListItem">Acupuncture is a drug-free treatment that may ease pain.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06814977' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2573 miles
Cleveland Clinic Florida Weston, Case Comprehensive Cancer Center
Weston,FL

VISITS: At least 3 visits in 6 months

PHASE: NA

NCT ID: NCT04365569

Personalized Nutrition and Exercise Counseling After Treatment for Women with Stage 0-III Breast Cancer

Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program on Body Weight, Composition, Cardiovascular Function and Quality of Life in Breast Cancer Survivors Scientific Title

Purpose

To study the ability of a personalized nutrition and exercise counseling program to improve the health and quality of life of women after breast cancer treatment.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed chemotherapy, immunotherapy, and/or radiation. You must have a BMI of at least 25 and receive care at Maroone Cancer Center in Weston, FL. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nutrition counseling with dietician, in person and by phone, 6 months</li> <li class="seamTextUnorderedListItem">Phone calls with dietician, monthly for 6 months</li> <li class="seamTextUnorderedListItem">Exercise, up to 2.5 hours every week for 6 months</li> <li class="seamTextUnorderedListItem">Body measurements, 3 times in 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">More than 65% of breast cancer survivors are overweight, and less than one-third participate in recommended levels of exercise.</li> <li class="seamTextUnorderedListItem">Obese breast cancer survivors are more than two times more likely to die than women with a normal body mass index (BMI).</li> <li class="seamTextUnorderedListItem">Providing some nutrition and exercise counseling by phone rather than all in person may reduce costs and increase participation.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04365569' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2574 miles
Montefiore Medical Center
Bronx,NY

VISITS: Coincides with surgery

PHASE: NA

NCT ID: NCT06524895

Reiki Before Surgery for Women with Stage 0-III Breast Cancer Who Live in Bronx County, NY

Pilot Study of Medical Reiki for Women Undergoing Surgery for Breast Cancer: Impact on Quality of Life, Medical Recovery Metrics, and Cortisol Scientific Title

Purpose

To study the impact of reiki before surgery on surgery recovery, quality of life, and stress.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who are planning to receive a mastectomy. You must live in Bronx County, New York. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Reiki, before surgery</li> </ul> Group 2: Placebo <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for reiki, before surgery</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Reiki is a form of energy therapy involving light touch. It is a process of targeting the energy fields around the patient's body and is believed to stimulate the patient's natural ability to heal itself.</li> <li class="seamTextUnorderedListItem">Reiki is a safe treatment that emphasizes spirituality in healing and wellness whose origins are rooted in ancient Tibetan traditions.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06524895' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2591 miles
University of Miami
Miami,FL

VISITS: Coincides with routine care

PHASE: NA

NCT ID: NCT04650256

Chinese Herbal Product to Reduce Pain and Itching from Radiation for Women with Stage II-III Breast Cancer

Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences Scientific Title

Purpose

To study a Chinese herbal product for the temporary relief of pain and itching after radiation.

Who is this for?

Women with stage II or some stage III breast cancer who have received a mastectomy and are planning to receive radiation. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will complete the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Rub product on your chest skin, daily for 4.5 months</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Chinese herbal product in this study is an over the counter (available without a prescription) product with 1% menthol.</li> <li class="seamTextUnorderedListItem">You will apply the product to your skin 2 times every day during radiation and continue for up to 3 months after radiation is complete.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04650256' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2591 miles
University of Miami
Miami,FL

VISITS: 2 visits in 2-3 months

PHASE: NA

NCT ID: NCT05721976

Improving Physical Activity and Diet for Hispanic Women After Treatment

Pilot Study of a Multigenerational Digital Lifestyle Intervention for Hispanic Female Cancer Survivors and Their Families Scientific Title

Purpose

To study the ability of the With Love, Grandma (Con Carino, Abuelita) digital lifestyle program to improve the physical activity and diet of Hispanic women cancer survivors and their adult daughters.

Who is this for?

Hispanic women with stage I, stage II, or stage III breast cancer who have completed treatment, are a grandmother with an adult daughter, own a smartphone, and live in South Florida. You must be overweight or engage in no more than 2.5 hours of physical activity per week. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">With Love, Grandma (Con Carino, Abuelita) digital lifestyle program, 2-3 months</li> <li class="seamTextUnorderedListItem">Video meetings with coach, weekly for 2-3 months</li> </ul> Group 2: Standard Treatment <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care intervention</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The With Love, Grandma (Con Carino, Abuelita) digital lifestyle program includes 8 modules on healthy lifestyle behaviors for cancer prevention and control, family behavior change content for setting weekly goals and self-monitoring health behaviors, and family communication and positive parenting/grandparenting.</li> <li class="seamTextUnorderedListItem">Your daughter will also participate in this trial.</li> <li class="seamTextUnorderedListItem">Each family will virtually meet with a coach for 15-30 minutes per week.</li> <li class="seamTextUnorderedListItem">This trial is available in English and Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05721976' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/exercise' target='_blank'>Breastcancer.org: Exercise</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/diet-nutrition' target='_blank'>Breastcancer.org: Diet and Nutrition</a> </li></ul>

NEAREST SITE: 2591 miles
University of Miami
Miami,FL

VISITS: Up to 1-2 visits every week for 2 months

PHASE: NA

NCT ID: NCT06534918

Diet and Exercise Program to Improve Healthy Behavior for People with Stage 0-III Breast Cancer

Precise Oncology Interventions in Nutrition and Training (OnPoint) Scientific Title

Purpose

To study if breast cancer survivors who receive a personal referral to a nutrition and exercise program will eat a healthier diet and be more physically active.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, or some stage III breast cancer who completed treatment at least 6 months ago. You must exercise less than 2.5 hours every week and/or not eat a healthy diet. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 4 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit, 2 months</li> <li class="seamTextUnorderedListItem">Text or phone call, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Nutrition class, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Exercise program, in person or virtual, 2 times every week for 2 months</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit, 2 months</li> <li class="seamTextUnorderedListItem">Text or phone call, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Nutrition class, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Exercise program, in person or virtual, 2 times every week for 2 months</li> <li class="seamTextUnorderedListItem">Checklist to monitor diet and exercise, 1 time</li> </ul> Group 3: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit, 2 months</li> <li class="seamTextUnorderedListItem">Text or phone call, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Nutrition class, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Exercise program, in person or virtual, 2 times every week for 2 months</li> <li class="seamTextUnorderedListItem">Meeting with dietician, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Meeting with exercise expert, weekly for 2 months</li> </ul> Group 4: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Personal sessions with diet and exercise experts may help people treated for breast cancer live healthier lifestyles.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06534918' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2619 miles
Dartmouth-Hitchcock Clinic
Lebanon,NH

VISITS: At least 2 visits within 3 months

PHASE: NA

NCT ID: NCT06258993

Promoting Exercise After Treatment for People With Stage 0-III Breast Cancer

Increasing Physical Activity Among Breast Cancer Survivors: Use of the ORBIT Model to Refine and Test a Novel Approach to Exercise Promotion Based on Affect-regulation (Study 2) Scientific Title

Purpose

To study the ability of 2 exercise programs to increase physical activity for breast cancer survivors.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment within the last 5 years. You must exercise less than 1 hour every week over the last 6 months. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Affect-Based Exercise <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visit to discuss exercise program, 2 times</li> <li class="seamTextUnorderedListItem">Exercise program</li> <li class="seamTextUnorderedListItem">Affect-based exercise, up to 2.5 hours every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Effort-Based Exercise <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visit to discuss exercise program, 2 times</li> <li class="seamTextUnorderedListItem">Exercise program</li> <li class="seamTextUnorderedListItem">Effort-based exercise, up to 2.5 hours every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise may improve fatigue, pain, quality of life, and sleep in people treated for breast cancer.</li> <li class="seamTextUnorderedListItem">The exercise program includes definitions of exercise, guidelines for safe exercise, and strategies to overcome barriers to exercise. You will also be asked to describe your previous exercise and will be given an exercise plan.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, you will be asked to <q>select a pace of exercise that makes you feel as good as possible.</q></li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will be asked to <q>select a pace that would make it challenging for you to carry on more than a short conversation.</q></li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06258993' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2693 miles
Dana Farber Cancer Institute
Boston,MA

VISITS: 4 visits over 8 months

PHASE: NA

NCT ID: NCT05327452

Exercise During Chemotherapy for Black and Hispanic People with Breast Cancer

Testing Home-based Exercise Strategies to Improve Exercise Participation and Cardiovascular Health in Underserved Minority Patients With Cancer Undergoing Chemotherapy: the THRIVE Study Scientific Title

Purpose

To determine whether an exercise intervention will affect physical activity levels and heart health in Black and Hispanic people with breast cancer.

Who is this for?

Black and Hispanic people newly diagnosed with stage I, stage II, or stage III breast cancer who are overweight/obese, engage in less than 90 minutes of exercise per week, and are planning to receive chemotherapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtually supervised home-based exercise, 3 times per week for 4 months</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Unsupervised home-based exercise, 3 times per week for 4 months</li> <li class="seamTextUnorderedListItem">Telehealth call with certified exercise trainer, 1 time per week for 4 months</li> </ul> Group 3 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Home-based stretching, 3 times per week for 4 months</li> </ul> Additional Procedures <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cardiovascular and strength tests, 3 times within 8 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 8 months</li> </ul> All groups require 4 visits
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The home-based exercise interventions include aerobic and resistance exercises.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, the virtual supervision will occur via Zoom.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05327452' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/exercise' target='_blank'>Breastcancer.org: Exercise</a> </li></ul>

NEAREST SITE: 2693 miles
Brigham and Women's Hospital
Boston,MA

VISITS: At least 3 visits in 9 months

PHASE: NA

NCT ID: NCT04724499

Exercise to Improve Brain and Heart Health During Chemotherapy for Women with Stage I-III Breast Cancer

Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy (The CLARITY Trial) Scientific Title

Purpose

To study if a high-intensity exercise program will improve brain health, heart function, and quality of life.

Who is this for?

Women newly diagnosed with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy before surgery (neoadjuvant). You must exercise less than 1 hour every week. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High-intensity exercise on stationary bike, in person or virtual, 3 times every week, 4 months</li> <li class="seamTextUnorderedListItem">MRI scans, 3 times within 9 months</li> <li class="seamTextUnorderedListItem">Bone scans</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Fitness tests</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Stretching, at home, 4 months</li> <li class="seamTextUnorderedListItem">MRI scans, 3 times in 9 months</li> <li class="seamTextUnorderedListItem">Bone scans</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Fitness tests</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High-intensity exercise on stationary bike, in person or virtual, 3 times every week, 4 months (optional)</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some people experience problems with brain function after chemotherapy.</li> <li class="seamTextUnorderedListItem">Some breast cancer treatments, such as chemotherapy, can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">Exercise may help improve brain function and heart function.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04724499' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2693 miles
Dana Farber Cancer Institute
Boston,MA

VISITS: 3 visits every week for 4 months, then 1 visit every month for 8 months

PHASE: NA

NCT ID: NCT04720209

Exercise to Decrease Inflammation in Fat and Prevent Recurrence for Women with Stage 0-III Breast Cancer

Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors Scientific Title

Purpose

To determine if an exercise program will decrease inflammation in fat tissue and reduce the risk of cancer recurrence (cancer coming back).

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who have completed treatment, have obesity (BMI >30), and exercise less than 1 hour every week. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Circuit-style aerobic and resistance exercise (CARE), 3 times every week for 4 months</li> <li class="seamTextUnorderedListItem">DEXA scan, 1 time</li> <li class="seamTextUnorderedListItem">Fat biopsy, 3 times (optional)</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Traditional aerobic resistance exercise (TARE), 3 times every week for 4 months</li> <li class="seamTextUnorderedListItem">DEXA scan, 1 time</li> <li class="seamTextUnorderedListItem">Fat biopsy, 3 times (optional)</li> </ul> Group 3: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Stretching exercise, at home, 4 months</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Circuit-style aerobic and resistance exercise (CARE), 3 times every week for 4 months (optional)</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise may reduce inflammation in fat tissue.</li> <li class="seamTextUnorderedListItem">Reducing inflammation in fat tissue may decrease the risk of cancer coming back that is related to being overweight or obese.</li> <li class="seamTextUnorderedListItem">Circuit-style exercise (group 1) means alternating between different exercises that use different muscle groups.</li> <li class="seamTextUnorderedListItem">A DEXA scan measures fat, muscle, and bone density.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04720209' target='_blank'>ClinicalTrials.gov</a> </li></ul>

NEAREST SITE: 2694 miles
MGH Institute of Health Professions
Boston,MA

VISITS: 5 visits within 5 months

PHASE: NA

NCT ID: NCT06052488

Group Exercise After Completing Treatment for Women with Stage I-III Breast Cancer

Strength After Breast Cancer: Clinical Implementation of an Evidence-based Group Exercise Intervention for Breast Cancer Survivors (SABC) Scientific Title

Purpose

To study if a group exercise program called Strength After Breast Cancer can be completed in a physical therapy clinic to improve physical function for women after breast cancer treatment.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who have completed treatment. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Individual physical therapy evaluation, 1 time</li> <li class="seamTextUnorderedListItem">Group exercise sessions, in person, 4 times within 5 months</li> <li class="seamTextUnorderedListItem">Surveys</li> <li class="seamTextUnorderedListItem">Interviews</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise in people who have been treated for breast cancer may reduce toxicity from treatment, increase time to tumor progression, and prolong survival.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06052488' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05056077

Tools to Improve Nutrition and Physical Activity After Treatment for People with Stage I-III Breast Cancer

Optimizing Intervention Tools to Improve Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) (TTBF) Scientific Title

Purpose

To study how 4 different support tools impact body weight, nutrition, and physical activity.

Who is this for?

People with stage I, stage II, or stage III breast cancer who have completed treatment (except for hormone therapy). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive a personalized report at the start of the study and then be randomly assigned to receive one or more of the following tools for approximately 1 year: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">A digital health tool kit or a food and exercise logbook</li> <li class="seamTextUnorderedListItem">Text messages</li> <li class="seamTextUnorderedListItem">Health coaching sessions</li> <li class="seamTextUnorderedListItem">Health coaching sessions for your support person</li> </ul> You will complete surveys on your background and health at the start of the study and update your health information a few times throughout the study.
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">People with a history of cancer whose nutrition and physical activity habits are consistent with the American Cancer Society's guidelines may live longer without cancer coming back (recurrence).</li> <li class="seamTextUnorderedListItem">The four components of the program being studied may help people with a history of cancer adopt recommended health behaviors after they have completed treatment.</li> <li class="seamTextUnorderedListItem">A support person of your choice will also participate in this study.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05056077' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06610097

Studying the Gut Microbiome During Neoadjuvant Treatment for Stage I-III Triple Negative Breast Cancer

Impacts of Diet, Activity, and Mood on a Dynamic Gut Microbiota During Treatment for Triple-negative Breast Cancer Scientific Title

Purpose

To study changes in the gut microbiome during neoadjuvant (before surgery) treatment for triple negative breast cancer.

Who is this for?

People with stage I, stage II, or stage III triple negative (ER-, PR-, HER2-) breast cancer. You must not be receiving before surgery (neoadjuvant) treatment or prebiotics or probiotics. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nutrition counseling, virtual, 3 sessions</li> <li class="seamTextUnorderedListItem">Surveys, 4 times in 6 months</li> <li class="seamTextUnorderedListItem">Stool (poop) samples, 4 times in 6 months</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Educational handout</li> <li class="seamTextUnorderedListItem">Surveys, 4 times in 6 months</li> <li class="seamTextUnorderedListItem">Stool (poop) samples, 4 times in 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The gut microbiome is made up of bacteria, viruses, and other organisms that live in the digestive tract and help keep us healthy. </li> <li class="seamTextUnorderedListItem">The gut microbiome changes in response to treatments for triple negative breast cancer, and this may lead to worse outcomes. </li> <li class="seamTextUnorderedListItem">The gut microbiome can be changed by changing the diet.</li> <li class="seamTextUnorderedListItem">To encourage participation and retention, you will be given a $40 gift certificate per stool sample with up to $200 total compensation.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06610097' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06938555

Fasting at Night to Improve Cognition After Chemotherapy for People with Stage I-IV Breast Cancer

The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors (RESTORE) Scientific Title

Purpose

To study how fasting at night affects health, quality of life, and cognitive ability.

Who is this for?

Women with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who completed chemotherapy at least 3 months ago and who are having cognitive (thinking) problems. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fast at night, 6 nights every week for 2 months</li> <li class="seamTextUnorderedListItem">Health education videos, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 2 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times in 2 months</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health education videos, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 2 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times in 2 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">When you are fasting, you are still allowed to drink water, coffee, and tea.</li> <li class="seamTextUnorderedListItem">Cognitive problems are problems with thinking (cognition).</li> <li class="seamTextUnorderedListItem">This trial's enrollment will be racially diverse (at least 50% of participants will be Black, Hispanic, and/or Native American).</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06938555' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT06392789

Text Messaging and Website to Improve Sleep Problems for Women with Stage I-III Breast Cancer

A Crossover Randomized Controlled Trial to Investigate the Acceptability and Efficacy of Cecebot, a Conversational Agent for Insomnia After Breast Cancer Scientific Title

Purpose

To study the ability of text message conversations with a chatbot to improve sleep problems.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who have completed treatment and have sleep problems. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Immediate Start <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Sleep education text message conversations with chatbot, 2-4 times every week</li> <li class="seamTextUnorderedListItem">Sleep education website, 2-4 times every week</li> <li class="seamTextUnorderedListItem">Wear activity tracker, daily for 1.5 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Delayed Start <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No intervention for 1.5 months</li> </ul> followed by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Sleep education text message conversations, 2-4 times every week</li> <li class="seamTextUnorderedListItem">Sleep education website, 2-4 times every week</li> <li class="seamTextUnorderedListItem">Wear activity tracker, daily for 1.5 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Sleep disturbance is a top concern of breast cancer survivors and is associated with poor quality of life. </li> <li class="seamTextUnorderedListItem">Many breast cancer survivors also have decreased physical activity, which may also have a negative impact on sleep and quality of life. </li> <li class="seamTextUnorderedListItem">Cognitive behavioral therapy (CBT) is a type of therapy that focuses on the relationship between thoughts, feelings, and behaviors.</li> <li class="seamTextUnorderedListItem">The chatbot in this study is called Cecebot and is a personalized text message-based behavioral intervention that combines cognitive behavioral therapy and exercise with the goal of improving sleep.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06392789' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: II

NCT ID: NCT05676255

Online Meditation to Reduce Anxiety and Depression After Treatment for Women with Stage I-III Breast Cancer

The SUPORT Project: Leveraging Social Connection by Including Informal Caregivers in an Internet Video Conference-based Compassion Meditation Intervention to Reduce Psychological Distress in Breast Cancer Survivors Scientific Title

Purpose

To study if meditation with or without caregivers will reduce depression and anxiety in breast cancer survivors.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who completed treatment between 3 months and 5 years ago. You may still be receiving hormone therapy or trastuzumab (Herceptin®). You must have a partner or caregiver who lives with you and is willing to participate. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Meditation sessions without your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Meditation sessions with your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 3: Health Education <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health education sessions with your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Many breast cancer survivors (around 70%) experience depression and/or anxiety after finishing cancer treatments.</li> <li class="seamTextUnorderedListItem">Meditation may reduce feelings of anxiety and depression.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05676255' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06388304

Online Program to Improve Attitudes About Hormone Therapy for Women with Stage 0-III HR+ Breast Cancer

Pilot Study of Positive Affect Training for Endocrine Therapy Medication Adherence (THRIVE) Scientific Title

Purpose

To study the THRIVE online behavioral program that aims to increase positive attitudes and decrease negative attitudes toward hormone therapy.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who have completed treatment. You must be receiving or recommended to receive hormone therapy and have concerns about hormone therapy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">THRIVE behavioral program, online</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Hormone therapy blocks the body's production of estrogen or response to estrogen.</li> <li class="seamTextUnorderedListItem">Side effects of hormone therapy may include bone or joint pain, hot flashes, fatigue, mood swings, and nausea.</li> <li class="seamTextUnorderedListItem">The THRIVE behavioral intervention is based on Positive Affect Training (PAT) and aims to improve attitudes about hormone therapy.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06388304' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT04754412

Writing to Heal: Writing Intervention After Treatment for Chinese-Born Women with Stage 0-III Breast Cancer

Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors Scientific Title

Purpose

To determine the health benefits of a culturally-based expressive writing intervention for Chinese-born women after treatment.

Who is this for?

Chinese-born women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who completed treatment less than 5 years ago. You must have lived in the US for at least 6 months. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Write about diagnosis and treatment, weekly for 3 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Write about stress, coping, and emotions, weekly for 3 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 3: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Write about positive thoughts and feelings about cancer experience, weekly for 3 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Culturally-based brief expressive writing interventions may help researchers learn more about the experiences of Chinese immigrant breast cancer survivors and how writing about their experiences may affect their health.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04754412' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mdanderson.org/publications/cancer-frontline/2019/expressive-writing-improves-quality-of-life-for-breast-cancer-su.html' target='_blank'>MD Anderson Cancer Center: Expressive writing improves quality of life for breast cancer survivors</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06582615

Healthy Eating and Nutrition Counseling to Improve Cognition During Chemotherapy for Women with Stage II-III Triple Negative Breast Cancer

Food for Thought - Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Triple Negative Breast Cancer (MIND-TNBC) Scientific Title

Purpose

To study if the MIND eating plan can improve memory and mental function, fatigue, sleep quality, anxiety, and depression.

Who is this for?

Women 40-65 years old with stage II or stage III triple negative (ER-, PR-, HER2-) breast cancer who are receiving (within the past 6 months) or planning to receive chemotherapy before surgery (neoadjuvant). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MIND counseling sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Personalized eating plan, 3 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General health sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> followed 6 months later by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MIND counseling sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Personalized eating plan, 3 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer treatment can lead to cognition (ability to think) problems and low quality of life.</li> <li class="seamTextUnorderedListItem">The Neurodegenerative Delay (MIND) eating plan is high in anti-inflammatory nutrients (omega-3, carotenoids, B vitamins, etc.) and limits foods that are not healthy for the brain (butter, cheese, red meat, fried foods, sugar, etc.).</li> <li class="seamTextUnorderedListItem">The MIND eating plan may help improve brain function during cancer treatment.</li> <li class="seamTextUnorderedListItem">In this trial, you will be sent some of the main foods in the MIND eating plan.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06582615' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://health.osu.edu/wellness/exercise-and-nutrition/the-mind-diet' target='_blank'>Ohio State University: The MIND Diet and Brain Health</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05452681

Improving Quality of Life of Young Black Women After Treatment

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors Scientific Title

Purpose

To compare how Y-AMBIENT education sessions and follow up phone calls improve quality of life after breast cancer treatment.

Who is this for?

Black or African American women ages 18 to 44 years old with stage I, stage II, or stage III breast cancer who have completed treatment with chemotherapy and/or radiation. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Y-AMBIENT education sessions, 3 times within 4 months</li> <li class="seamTextUnorderedListItem">Y-AMBIENT follow up phone calls, 3 times within 4 months</li> </ul> Group 2 <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education sessions, 3 times within 4 months</li> <li class="seamTextUnorderedListItem">Follow up phone calls, 3 times within 4 months</li> </ul> Additional Procedures <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Y-AMBIENT is telephone-based intervention with education sessions designed to improve quality of life. Session 1, titled <q>My Self, My Soul,</q> covers topics related to spiritual growth and finding meaning in illness. Session 2, titled <q>My Body,</q> covers topics related to breast changes, aches/pains, fatigue, and weight changes. Session 3, titled <q>My Mind and My Relationships,</q> covers topics related to anxiety, fear, and relationships with others.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, education sessions include a culturally-targeted cookbook and a guide to grocery shopping smart.</li> <li class="seamTextUnorderedListItem">For both groups, all sessions will take approximately one hour, and follow-up phone calls will last about 20 minutes.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05452681' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.komen.org/breast-cancer/survivorship/health-concerns/quality-of-life/#:~:text=Quality%20of%20life%20after%20treatment,even%20years%20after%20treatment%20ends.' target='_blank'>Susan G. Komen: Quality of Life After Breast Cancer Treatment</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cdc.gov/pcd/issues/2016/16_0096.htm' target='_blank'>Centers for Disease Control and Prevention: Quality of Life of Black Breast Cancer Survivors</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06397651

Impact of Digital Exercise Coaching on Well-Being and Cost of Care for People with Stage I-IV Breast Cancer

A Decentralized, Double-blinded, Randomized, 18 Month, Parallel-group, Superiority Study to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalized Digital Application on Cancer Survivors' Cost of Care Scientific Title

Purpose

To study the ability of a personalized and interactive exercise program to reduce healthcare costs and improve health outcomes.

Who is this for?

People 21-64 years old with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who have received treatment in the last year. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Live exercise coaching sessions using digital app, 3-5 sessions every week, 6 months</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Access to digital app about lifestyle modifications, 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">If you are in group 1, the sessions will focus on exercise and meditation with additional information on diet, sleep, and other lifestyle practices.</li> <li class="seamTextUnorderedListItem">If you are in group 2, the digital app includes expert guidelines on lifestyle modification focusing on exercise, meditation, as well as information on diet, sleep and other lifestyle practices.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06397651' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: II

NCT ID: NCT06728579

Group Therapy to Manage Joint Pain From Hormone Therapy for Women with Stage I-III HR+ Breast Cancer

Enhanced Pain Coping in Cancer (EPIC) Scientific Title

Purpose

To study if group therapy can help breast cancer survivors manage joint pain caused by aromatase inhibitors.

Who is this for?

Women with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who completed treatment at least 1 month ago. You must be receiving letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®) aromatase inhibitor and be planning to continue for at least 1 year. You must have joint pain. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Group therapy that includes mindfulness and other coping strategies, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Practice learned skills, at home, 15 minutes every day for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Group therapy that includes discussion on chronic pain and cancer survivorship, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Write in a journal, at home, 15 minutes every day for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Joint pain is common in people taking aromatase inhibitors. This pain can make some people decide to stop taking their medication. </li> <li class="seamTextUnorderedListItem">This study will look at the effects of 2 different types of group therapy on your cancer-related symptoms (such as pain, fatigue, and anxiety), your ability to continue taking aromatase inhibitors on a regular schedule, and your quality of life.</li> <li class="seamTextUnorderedListItem">All sessions in Group 1 and Group 2 are 2 hours each.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06728579' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05053230

Integrative Medicine at Home Program for People With Stage I-IV Breast Cancer

Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE) Scientific Title

Purpose

To find out whether the Integrative Medicine at Home program can help reduce symptoms and improve treatment satisfaction.

Who is this for?

People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are currently receiving treatment. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Integrative Medicine at Home program, 3 months</li> </ul> Group 2: Enhanced Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Integrative medicine handout</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Integrative Medicine at Home program offers virtual (online rather than in-person) group classes focusing on mind-body practice.</li> <li class="seamTextUnorderedListItem">Mind-body practice is a health practice that combines mental focus, controlled breathing, and body movements to help relax the body and mind and reduce symptoms such as tiredness (fatigue), pain, or insomnia (sleep problems).</li> <li class="seamTextUnorderedListItem">The classes will be led by an Integrative Medicine Service (IMS) clinical therapist using Zoom video conferencing platform.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will be given a handout to encourage you to visit Memorial Sloan Kettering's Integrative Medicine website to access pre-recorded, on-demand meditation videos and audios.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05053230' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine' target='_blank'>Memorial Sloan Kettering Cancer Center: Integrative Medicine</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05810025

RealRisks Online Program for Breast Cancer Risk Assessment

Integrating EHR and Patient-generated Health Data for Breast Cancer Risk Assessment and Decision Support in a Diverse Multiethnic Population Scientific Title

Purpose

To study how the RealRisks program promotes understanding of breast cancer risk and prevention and perceptions by users of their risk for breast cancer.

Who is this for?

Women, age 35-74 years old, at high risk for breast cancer but who have not been diagnosed with breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Use of the RealRisks program, online</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">RealRisks is a web-based patient-centered program designed to improve: 1) accurate understanding of breast cancer risk; 2) knowledge about drugs that could prevent breast cancer, and 3) making choices based on information. RealRisks includes audio and modules about breast cancer risk (including interactive games on risk communication) and drugs that could prevent breast cancer. </li> <li class="seamTextUnorderedListItem">Through RealRisks, study investigators will collect information on breast cancer risk factors to calculate a person's breast cancer risk score and also factors that influence decision-making about prevention. </li> <li class="seamTextUnorderedListItem">RealRisks generates an action plan for patients summarizing their personalized breast cancer risk and preference for prevention.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05810025' target='_blank'>ClinicalTrials.gov</a> </li></ul>